Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin)
decreases the number of people who die as a result of Disseminated Intravascular Coagulation
(DIC) complication of sepsis.